Evidence map›Paper›PMID 42151146›Full record

ArticleNature communications2026

Joint clinical and molecular subtyping of COPD with variational autoencoders.

Enrico Maiorino, Margherita De Marzio, Zhonghui Xu, Jeong H Yun, Robert P Chase, Craig P Hersh, Don D Sin, Scott T Weiss, Edwin K Silverman, Peter J Castaldi and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Enrico MaiorinoChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA. reema@channing.harvard.edu.ORCID http://orcid.org/0000-0002-0159-4221
Margherita De MarzioChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1821-208X
Zhonghui XuChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Jeong H YunChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4361-8295
Robert P ChaseChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.ORCID http://orcid.org/0000-0003-1183-0619
Craig P HershChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Don D SinCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.ORCID http://orcid.org/0000-0002-0756-6643
Scott T WeissChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Edwin K SilvermanChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Peter J CastaldiChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Kimberly GlassChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA. kimberly.glass@channing.harvard.edu.ORCID http://orcid.org/0000-0003-4394-5779

Funding

Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
GENETIC EPIDEMIOLOGY OF COPD (COPD GENE) TASK A: STUDY VISIT 4, COLLECTION OF COPDGENE STUDY DATA ANDBIOSPECIMENS AND OVERSIGHT OF THE COPDGENE STUDY75N92023D00011 · NHLBI · NATIONAL JEWISH HEALTH · PI NEWMAN, LEE S · 2023 to 2025
$29.6M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
Systems Biology of Airway DiseaseP01HL132825 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI RABY, BENJAMIN ALEXANDER · 2016 to 2020
$12.6M
Using Integrative Genomics To Identify and Characterize Emphysema-Associated eQTLR01HL124233 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CASTALDI, PETER · 2014 to 2024
$7.1M
Leveraging Variant-perturbed Gene Regulation to Support Precision Medicine in COPDR01HL155749 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Kimberly Renee Glass · 2022 to 2026
$4.2M
The role of COPD genetic risk factor HHIP on lymphocytic inflammationK08HL146972 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI YUN, JEONG H · 2020 to 2024
$848k
Mechanogenomics of the asthmatic airway epitheliumK25HL168157 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Margherita De Marzio · 2023 to 2026
$753k
Linking endotype and phenotype to understand COPD heterogeneity via deep learning and network scienceK01HL166705 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Enrico Maiorino · 2023 to 2026
$713k
NHLBI NIH HHS 75N92023D00011NHLBI NIH HHS K01 HL166705NHLBI NIH HHS K08 HL146972NHLBI NIH HHS K25 HL168157NHLBI NIH HHS P01 HL132825NHLBI NIH HHS R01 HL124233NHLBI NIH HHS R01 HL155749NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) K01HL166705U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) K25HL168157U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) PO1HL132825U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL124233U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL155749
6 · The paper itself

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is a complex, heterogeneous disease. Traditional subtyping methods generally focus on either the clinical manifestations or the molecular endotypes of the disease, leading to classifications that only partially reflect disease heterogeneity. Here, we introduce a variational autoencoder-based subtyping pipeline that jointly embeds clinical and gene expression data into a single subject-level representation. We evaluate the framework in the COPDGene study, a large study of current and former smoking individuals with and without COPD. Prediction experiments show that the embeddings have predictive accuracy comparable to or better than other unsupervised embedding approaches. Using trajectory learning approaches, we identify five well-separated subtypes with distinct clinical phenotypes, expression signatures, and longitudinal outcomes. Finally, we show that our findings generalize to an external validation cohort. Overall, our approach enables a transition from isolated phenotypic or molecular subtyping toward an integrated and clinically meaningful understanding of COPD heterogeneity.

Indexed as

Pulmonary Disease, Chronic ObstructiveAutoencoderGene Expression ProfilingHumansPhenotypeSmoking

Identifiers

PMID42151146
PMCPMC13392298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.